Immunology and Microbiology
Inflammatory Arthritis
100%
Synovial Fluid
56%
Fibroblast
45%
Fibroblast-Like Synoviocyte
44%
Ecalectin
39%
Secretion (Process)
27%
Interleukin-6
21%
Osteoclastogenesis
21%
Cytokine
21%
Blood Plasma
20%
Autoantibodies
19%
Immune Receptor
19%
Lymphocyte Activation
19%
Interleukin 20
19%
Juvenile Idiopathic Arthritis
19%
Galectin 3
19%
Apremilast
19%
Rituximab
19%
Vaccination Policy
19%
Autoimmune Rheumatic Disease
19%
COVID-19
19%
Heme
19%
Oxygenase
19%
Mononuclear Cell
18%
Peripheral Blood Mononuclear Cell
13%
Coculture
11%
Disease-Modifying Antirheumatic Drug
10%
Monocyte Chemotactic Protein 1
9%
Blood Level
8%
Monocyte
7%
Vaccine Efficacy
6%
CD137 Ligand
6%
Tocilizumab
6%
Tofacitinib
6%
Osteoclast
6%
T Cell
5%
Keyphrases
Autoantibodies
19%
IL-20
19%
Cytokine Inhibitors
19%
Inflammatory Arthritis
19%
Interleukin-20
19%
Cellular Composition
19%
Disease-associated
19%
IL-24
19%
Post-pandemic
19%
Pandemic Fear
19%
Serological Response
19%
Autoimmune Rheumatic Diseases
19%
Rituximab
19%
COVID-19 Vaccination
19%
Rituximab Therapy
19%
Rheumatoid Arthritis
12%
Rheumatoid Arthritis Patients
12%
Baricitinib
11%
IL-22R1
9%
IL-19
9%
Ex Vivo Model
7%
Immune Complex
7%
Pharmacology, Toxicology and Pharmaceutical Science
Rheumatoid Arthritis
39%
Ecalectin
19%
Apremilast
19%
Cytokine
19%
Inflammatory Arthritis
19%
Oxygenase
19%
Heme
19%
Biological Marker
19%
Disease Modifying Antirheumatic Drug
10%
Disease
8%
CD137 Ligand
6%
Tofacitinib
6%
Baricitinib
6%
Tocilizumab
6%